Dexcom (DXCM) Amortization of Deferred Charges (2010 - 2016)

Dexcom (DXCM) has 6 years of Amortization of Deferred Charges data on file, last reported at $100000.0 in Q3 2016.

• On a quarterly basis, Amortization of Deferred Charges changed 0.0% year-over-year to $100000.0 in Q3 2016; TTM through Sep 2016 was $100000.0, a 50.0% decrease from a year earlier, with the FY2015 full-year figure at $200000.0, down 33.33% from the prior year.
• Amortization of Deferred Charges for Q3 2016 stood at $100000.0, roughly flat from $100000.0 in the prior quarter.
• Over the last five years, Amortization of Deferred Charges for DXCM reached as high as $200000.0 in Q2 2013 and fell as low as $100000.0 in Q4 2012.
• Historically, Amortization of Deferred Charges has averaged $110000.0 across 5 years, with a median of $100000.0 in 2012.
• Across the five-year window, Amortization of Deferred Charges changed 0.0% in 2013 and slumped 50.0% in 2014, its largest moves.
• Year by year, Amortization of Deferred Charges stood at $100000.0 in 2012, then changed by 0.0% to $100000.0 in 2013, then changed by 0.0% to $100000.0 in 2014, then changed by 0.0% to $100000.0 in 2015, then changed by 0.0% to $100000.0 in 2016.
• Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $100000.0 in Q3 2016, $100000.0 in Q3 2015, and $100000.0 in Q1 2015.